In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer

Journal of Controlled Release

Volumn 209, Issue , 2015, Pages 88-100

  Alibolandi, Mona ^a   Ramezani, Mohammad ^a,b   Abnous, Khalil ^b   Sadeghi, Fatemeh ^a,c   Atyabi, Fatemeh ^d   Asouri, Mohsen ^e   Ahmadi, Ali Asghar ^e   Hadizadeh, Farzin ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Doxorubicin; Epithelial cell adhesion molecule; Nanopolymersome; Non small cell lung cancer; PEG PLGA; SK MES 1

Indexed keywords

BIOLOGICAL MATERIALS; BIOLOGICAL ORGANS; BIOMOLECULES; CELL ADHESION; CELL CULTURE; COPOLYMERS; CYTOLOGY; CYTOTOXICITY; DISEASES; MAMMALS; MOBILE SECURITY; MOLECULES; NANOPARTICLES; TUMORS;

DOXORUBICIN; EPITHELIAL CELL ADHESION MOLECULES; NANOPOLYMERSOME; NON SMALL CELL LUNG CANCER; SK-MES-1;

CELLS;

APTAMER; DOXORUBICIN; EPITHELIAL CELL ADHESION MOLECULE; FLUOROPYRIMIDINE; NANOPARTICLE; POLYGLACTIN; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; MACROGOL DERIVATIVE; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; PYRIMIDINE DERIVATIVE; TUMOR ANTIGEN; TUMOR-ASSOCIATED ANTIGEN GA733;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER SURVIVAL; CANCER THERAPY; CHEMICAL REACTION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VOLUME; TUMOR XENOGRAFT; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; GENETICS; HEART; LUNG NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; APTAMERS, NUCLEOTIDE; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DOXORUBICIN; ERYTHROCYTES; HEART; HEMOLYSIS; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; PYRIMIDINES; TUMOR BURDEN;

EID: 84929118901     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.04.026     Document Type: Article

References (72)

1. American Lung Association Trends in lung cancer morbidity and mortality, epidemiology and statistics unit: research and scientific affairs http://www. lung.org/lung-disease/lung-cancer/learning-more-about-lung-cancer/understanding lung-cancer/ (Accessed 31 January 2015)
2. C.S. Dela Cruz, L.T. Tanoue, and R.A. Matthay Lung cancer: epidemiology, etiology, and prevention Clin. Chest Med. 32 2011 605 644
3. Cochrane Database of Systematic Reviews Non-small Cell Lung Cancer Collaborative Group Chemotherapy can improve survival rates for non-small cell lung cancer http://summaries.cochrane.org/CD002139/chemotherapy-can-improve-survival-rates-for-non-small-cell-lung-cancer 2010
4. A. Fiorelli, D. Sagan, L. Mackiewicz, L. Cagini, E. Scarnecchia, P. Chiodini, F.P. Caronia, F. Puma, M. Santini, and M. Ragusa Incidence, risk factors, and analysis of survival of unexpected N2 disease in stage I non-small cell lung cancer Thorac. Cardiovasc. Surg. Jan. 28, 2015 10.1055/s-0034-1399764
5. W. Liang, L. Zhang, G. Jiang, Q. Wang, L. Liu, D. Liu, Z. Wang, Z. Zhu, Q. Deng, X. Xiong, W. Shao, X. Shi, and J. He Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer J. Clin. Oncol. 33 2015 861 869
6. Y.B. Gesthalter, J. Vick, K. Steiling, and A. Spira Translating the transcriptome into tools for the early detection and prevention of lung cancer Thorax Jan 27 2015 10.1136/thoraxjnl-2014-206605 (pii: thoraxjnl-2014-206605)
7. M. Malvezzi, P. Bertuccio, T. Rosso, M. Rota, F. Levi, C. La Vecchia, and E. Negri European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann. Oncol. Jan 26 2015 10.1093/annonc/mdv001
8. H. Wu, Y. Zhao, X. Mu, H. Wu, L. Chen, W. Liu, Y. Mu, J. Liu, and X. Wei A silica-polymer composite nano system for tumor-targeted imaging and p53 gene therapy of lung cancer J. Biomater. Sci. Polym. Ed. 27 2015 1 23
9. S. Hamarat SanlIer, M. Yasa, A.O. Cihnioglu, M. Abdulhayoglu, H. YIlmaz, and G. Ak Development of gemcitabine-adsorbed magnetic gelatin nanoparticles for targeted drug delivery in lung cancer Artif. Cells Nanomed. Biotechnol. 23 2015 1 7
10. N. Mar, J.J. Vredenburgh, and J.S. Wasser Targeting HER2 in the treatment of non-small cell lung cancer Lung Cancer Jan. 8, 2015 10.1016/j.lungcan.2014.12.018 (pii: S0169-5002(14)00528-5)
11. J. Emami, A. Pourmashhadi, H. Sadeghi, J. Varshosaz, and H. Hamishehkar Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy Pharm. Dev. Technol. 19 2014 1 10
12. X. Wang, C. Yang, Y. Zhang, X. Zhen, W. Wu, and X. Jiang Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles Biomaterials 35 2014 6439 6453
13. Y. Han, P. Zhang, Y. Chen, J. Sun, and F. Kong Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy Int. J. Mol. Med. 34 2014 191 196
14. J.K. Yan, H.L. Ma, X. Chen, J.J. Pei, Z.B. Wang, and J.Y. Wu Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin Int. J. Biol. Macromol. 72C 2014 333 340
15. Y. Song, Z. Huang, Y. Song, Q. Tian, X. Liu, Z. She, J. Jiao, E. Lu, and Y. Deng The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient Int. J. Nanomedicine 9 2014 3611 3621
16. I. Levacheva, O. Samsonova, E. Tazina, M. Beck-Broichsitter, S. Levachev, B. Strehlow, M. Baryshnikova, N. Oborotova, A. Baryshnikov, and U. Bakowsky Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof Colloids Surf. B: Biointerfaces 121 2014 248 256
17. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzym. Regul. 41 2001 189 207
18. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
19. M. Nakamura, K. Hayashi, M. Nakano, T. Kanadani, K. Miyamoto, T. Kori, and K. Horikawa Identification of polyethylene glycol-resistant macrophages on stealth imaging in vitro using fluorescent organosilica nanoparticles ACS Nano 9 2015 1058 1071
20. F. Zhang, S. Zhang, S.F. Pollack, R. Li, A.M. Gonzalez, J. Fan, J. Zou, S.E. Leininger, A. Pavía-Sanders, R. Johnson, L.D. Nelson, J.E. Raymond, M. Elsabahy, D.M. Hughes, M.W. Lenox, T.P. Gustafson, and K.L. Wooley Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers J. Am. Chem. Soc. 137 2015 2056 2066
21. T.H. Tran, C.T. Nguyen, L. Gonzalez-Fajardo, D. Hargrove, D. Song, P. Deshmukh, L. Mahajan, D. Ndaya, L. Lai, R.M. Kasi, and X. Lu Long circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumors Biomacromolecules 15 2014 4363 4375
22. L. Zhang, T. Su, B. He, and Z. Gu Self-assembly polyrotaxanes nanoparticles as carriers for anticancer drug methotrexate delivery Nano-Micro Lett. 6 2014 108 115
23. U.K. Sukumar, B. Bhushan, P. Dubey, I. Matai, A. Sachdev, and G. Packirisamy Emerging applications of nanoparticles for lung cancer diagnosis and therapy Int. Nano Lett. 3 2013 45
24. M. Deshmukh, H.L. Kutscher, D. Gao, V.R. Sunil, R. Malaviya, K. Vayas, S. Stein, J.D. Laskin, D.L. Laskin, and P.J. Sinko Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates Control Release 164 2012 65 73 10.1016/j.jconrel.2012.09.011
25. P. Kaur, T. Garg, G. Rath, R.S. Murthy, and A.K. Goyal Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design Drug Deliv. 29 2014 1 14
26. T.R. Arunraj, N. Sanoj Rejinold, N. Ashwin Kumar, and R. Jayakumar Doxorubicin-chitin-poly(caprolactone) composite nanogel for drug delivery Int. J. Biol. Macromol. 62 2013 35 43 10.1016/j.ijbiomac.2013.08.013
27. W. Wei, Y. Mu, X. Li, M. Gou, H. Zhang, S. Luo, K. Men, Y. Mao, Z. Qian, and L. Yang Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo J. Biomed. Nanotechnol. 7 2011 768 775
28. E.M. Perchellet, J.P. Perchellet, C.K. Ganta, D.L. Troyer, A. Shi, and D.H. Hua Synthesis, molecular targets, and antitumor activities of substituted tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans and nanogels for drug delivery Anticancer Agents Med Chem. 9 2009 864 876
29. O.B. Garbuzenko, G. Mainelis, O. Taratula, and T. Minko Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention Cancer Biol. Med. 11 2014 44 55 10.7497/j.issn.2095-3941.2014.01.004
30. X. Guo, X. Zhang, L. Ye, Y. Zhang, R. Ding, Y. Hao, Y. Zhao, Z. Zhang, and Y. Zhang Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol J. Drug Target. 22 2014 421 427 10.3109/1061186X.2013.878944
31. L. Dai, L. Wang, L. Deng, J. Liu, J. Lei, D. Li, and J. He Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer Sci. Rep. 4 2014 5871 10.1038/srep05871
32. Y.D. Heryanto, A. Achmad, A. Taketomi-Takahashi, and Y. Tsushima In vivo molecular imaging of cancer stem cells Am. J. Nucl. Med. Mol. Imaging 5 2014 14 26
33. M.C. Cabrera, R.E. Hollingsworth, and E.M. Hurt Cancer stem cell plasticity and tumor hierarchy World J. Stem Cells 7 2015 27 36 10.4252/wjsc.v7.i1.27
34. W. Sterlacci, S. Savic, M. Fiegl, E. Obermann, and A. Tzankov Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization J. Thorac. Oncol. 9 2014 41 49
35. S.V. Litvinov, M. Balzar, M.J. Winter, H.A. Bakker, I.H. Briaire-de Bruijn, F. Prins, G.J. Fleuren, and S.O. Warnaar Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins J. Cell Biol. 139 1997 1337 1348
36. O. Gires, and N.H. Stoecklein Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences Cell. Mol. Life Sci. 71 2014 4393 4402
37. M.J. Winter, V. Cirulli, I.H. Briaire-de Bruijn, and S.V. Litvinov Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase Mol. Cell. Biochem. 302 2007 19 26
38. F. Tas, S. Karabulut, and D. Duranyildiz Clinical significance of serum epithelial cell adhesion molecule (EPCAM) levels in patients with lung cancer Mol. Cell. Biochem. 396 2014 307 312 10.1007/s11010-014-2167-3
39. K. Schulze, C. Gasch, K. Staufer, B. Nashan, A.W. Lohse, K. Pantel, S. Riethdorf, and H. Wege Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma Int. J. Cancer 133 2013 2165 2171 10.1002/ijc.28230
40. S. Naundorf, S. Preithner, P. Mayer, S. Lippold, A. Wolf, F. Hanakam, I. Fichtner, P. Kufer, T. Raum, G. Riethmuller, P.A. Baeuerle, and T. Dreier In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment Int. J. Cancer 100 2002 101 110
41. N. Prang, S. Preithner, K. Brischwein, P. Goster, A. Woppel, J. Muller, C. Steiger, M. Peters, P.A. Baeuerle, and A.J. da Silva Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines Br. J. Cancer 92 2005 342 349
42. G. Himmler, H. Loibner, M. Schuster, E. Janzek, S. Stranner, and H. Samonigg Murine monoclonal antibody 17-1A used as vaccine antigen (IGN101): direct induction of anti-EpCAM antibodies by vaccination of cancer patients Proc. Am. Soc. Clin. Oncol. 22 2003 A732
43. J.S. de Bono, A.W. Tolcher, A. Forero, G.F. Vanhove, C. Takimoto, R.J. Bauer, L.A. Hammond, A. Patnaik, M.L. White, S. Shen, M.B. Khazaeli, E.K. Rowinsky, and A.F. LoBuglio ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas Clin. Cancer Res. 10 2004 7555 7565
44. C. Di Paolo, J. Willuda, S. Kubetzko, I. Lauffer, D. Tschudi, R. Waibel, A. Pluckthun, R.A. Stahel, and U. Zangemeister-Wittke A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity Clin. Cancer Res. 9 2003 2837 2848
45. S. Zimmermann, W. Wels, B.A. Froesch, B. Gerstmayer, R.A. Stahel, and U. Zangemeister-Wittke A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer Cancer Immunol. Immunother. 44 1997 1 9
46. S.D. Jayasena Aptamers: an emerging class of molecules that rival antibodies in diagnostics Clin. Chem. 45 1999 1628 1650
47. M. Alibolandi, M. Ramezani, F. Sadeghi, K. Abnous, and F. Hadizadeh Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro Int. J. Pharm. 479 2015 241 251 10.1016/j.ijpharm.2014.12.035
48. S. Shigdar, J. Lin, Y. Yu, M. Pastuovic, M. Wei, and W. Duan RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule Cancer Sci. 102 2011 991 998 10.1111/j.1349-7006.2011.01897.x
49. B. Jeong, Y.K. Choi, Y.H. Bae, G. Zentner, and S.W. Kim New biodegradable polymers for injectable drug delivery systems J. Control. Release 62 1999 109 114
50. Bolotin et al. Liposomal Bupivacaine compositions prepared using an ammonium sulfate gradient, U.S.Patent, No.6162462.
51. N.V. Cuong, J.L. Jiang, Y.L. Li, J.R. Chen, S.C. Jwo, and M.F. Hsieh Doxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of Nude mice: effect of multiple administration of micelle on the suppression of human breast cancer Cancers (Basel) 3 2010 61 78 10.3390/cancers3010061
52. M. Amin, A. Badiee, and M.R. Jaafari Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas Int. J. Pharm. 458 2013 324 333 10.1016/j.ijpharm.2013.10.018
53. Y. Wang, L. Hosta-Rigau, H. Lomas, and F. Caruso Nanostructured polymer assemblies formed at interfaces: applications from immobilization and encapsulation to stimuli-responsive release Phys. Chem. Chem. Phys. 13 2011 4782 4801
54. F. Li, L.H.J. de Haan, A.T.M. Marcelis, F.A.M. Leermakers, M.A. Cohen Stuart, and E.J.R. Sudhölter Pluronic polymersomes stabilized by core cross-linked polymer micelles Soft Matter 5 2009 4042 4046
55. H. Lu, L. Fan, Q. Liu, J. Wei, T. Ren, and J. Du Preparation of water-dispersible silver-decorated polymer vesicles and micelles with excellent antibacterial efficacy Polym. Chem. 3 2012 2217 2227
56. O. Kayser, A. Lemke, and N. Hernández-Trejo The impact of nanobiotechnology on the development of new drug delivery systems Curr. Pharm. Biotechnol. 6 2005 3 5
57. C.W. Gan, S. Chien, and S.S. Feng Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation Curr. Pharm. 16 2010 2308 2320
58. L. Li, D. Xiang, S. Shigdar, W. Yang, Q. Li, J. Lin, K. Liu, and W. Duan Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells Int. J. Nanomedicine 9 2014 1083 1096 10.2147/IJN.S59779. eCollection 2014
59. B. Magenheim, M.Y. Levy, and S. Benita A new in vitro technique for evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure Int. J. Pharm. 94 1993 115 123
60. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
61. Y. Kim, H.S. Kim, Z.Y. Cui, H.S. Lee, J.S. Ahn, C.K. Park, K. Park, and M.J. Ahn Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung Anticancer Res. 29 2009 1817 1822
62. J. Xu, Q. Zhao, Y. Jin, and L. Qiu High loading of hydrophilic/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy Nanomedicine 10 2014 349 358 10.1016/j.nano.2013.08.004
63. S. Everitt, A. Herschtal, J. Callahan, N. Plumridge, D. Ball, T. Kron, M. Schneider-Kolsky, D. Binns, R.J. Hicks, and M. MacManus High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with non-small cell lung cancer Cancer 116 2010 5030 5037 10.1002/cncr.25392
64. K. Li, R.Y. Sung, W.Z. Huang, M. Yang, N.H. Pong, S.M. Lee, W.Y. Chan, H. Zhao, M.Y. To, T.F. Fok, C.K. Li, Y.O. Wong, and P.C. Ng Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin Circulation 113 2006 2211 2220
65. A.M. Rahman, S.W. Yusuf, and M.S. Ewer Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation Int. J. Nanomedicine 2 2007 567 583
66. D.S. Alberts, F.M. Muggia, J. Carmichael, E.P. Winer, M. Jahanzeb, A.P. Venook, K.M. Skubitz, E. Rivera, J.A. Sparano, N.J. DiBella, S.J. Stewart, J.J. Kavanagh, and A.A. Gabizon Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials Semin. Oncol. 31 2004 53 90
67. R.H. Prabhu, V.B. Patravale, and M.D. Joshi Polymeric nanoparticles for targeted treatment in oncology: current insights Int. J. Nanomedicine 10 2015 1001 1018
68. W.H. Chiang, W.C. Huang, C.W. Chang, M.Y. Shen, Z.F. Shih, Y.F. Huang, S.C. Lin, and H.C. Chiu Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging J. Control. Release 168 2013 280 288
69. N. Oishi, T. Yamashita, and S. Kaneko Molecular biology of liver cancer stem cells Liver Cancer 3 2014 71 84 10.1159/000343863
70. D. Fong, A. Seeber, L. Terracciano, A. Kasal, G. Mazzoleni, F. Lehne, G. Gastl, and G. Spizzo Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas J. Clin. Pathol. 67 2014 408 414 10.1136/jclinpath-2013-201932
71. C. Patriarca, R.M. Macchi, A.K. Marschner, and H. Mellstedt Epithelial cell adhesion molecule expression (CD326) in cancer: a short review Cancer Treat. Rev. 38 2012 68 75 10.1016/j.ctrv.2011.04.002
72. S. Shigdar, C. Qian, L. Lv, C. Pu, Y. Li, L. Li, M. Marappan, J. Lin, L. Wang, and W. Duan Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy Nanomedicine 11 2015 379 389 10.1016/j.nano.2014.09.002